Endoscopic sleeve gastroplasty vs sleeve gastrectomy

Endoscopic sleeve gastroplasty (ESG) and laparoscopic sleeve gastrectomy are not two ways to perform the same operation. ESG uses an endoscope passed through the mouth to place full-thickness sutures that reduce gastric volume without removing stomach; sleeve gastrectomy is abdominal surgery that removes most of the stomach and leaves a stapled gastric sleeve. Their eligibility frameworks, expected effects, risks, nutrition, durability evidence, follow-up, conversion options, and coverage must be compared separately.¹³⁴

ESG gained a Category I CPT code effective January 1, 2026.⁴ A billing code is not FDA approval, a coverage guarantee, or proof that two procedures are equivalent.

The anatomy is the first decisive difference

“Incisionless” describes no external abdominal incision, not no tissue injury, anesthesia, pain, bleeding, perforation risk, sutures or recovery.

FDA authorization belongs to the exact device and use

FDA granted De Novo classification for a named endoscopic suturing system for a bounded weight-management use.²³ That decision creates a device category and special controls; it does not approve every ESG technique, suture pattern, patient, center, claim or outcome.

Verify:

• exact device and accessories;
• current indications and contraindications;
• clinician training and endoscopy privileges;
• facility and anesthesia team;
• procedure-specific emergency and surgical backup;
• suture pattern and number planned;
• device lot/traceability record; and
• what happens if anatomy prevents completion.

Sleeve gastrectomy is a surgical procedure, not an FDA-approved product. Individual staplers and devices may have their own authorizations; those do not certify the entire operation or surgeon.

Eligibility is a program decision, not a BMI contest

Body-mass index can help define studied or covered populations, but it does not replace evaluation of weight history, metabolic disease, reflux, eating patterns, prior stomach surgery, medicines, pregnancy plans, sleep apnea, cardiopulmonary risk, nutrition, mental health, substance use, goals, prior therapies and ability to follow longitudinal care.

Do not select ESG because a clinic calls it “for lower BMI” or surgery because it “loses more weight” without the exact eligibility framework and tradeoffs. The GLP-1-versus-bariatric-surgery guide shows how to compare medication and operations; this page stays within two procedural paths.

The assessment should also ask whether reflux, hiatal hernia, altered anatomy or another finding changes the preferred procedure or requires a different operation. That is individualized clinical work, not a web checklist answer.

Comparative weight numbers need the same denominator

Studies may report total body weight loss, excess weight loss, BMI change, metabolic markers, quality of life, medicine use, reintervention or adverse events at different time points. Those endpoints cannot be mixed.

Recent meta-analyses generally find greater average weight loss after surgical sleeve in compared cohorts, shorter hospitalization with ESG, and mixed or comparable short-term major-adverse-event findings; most comparisons are not randomized and selection differs.⁵⁶ People choosing ESG may start with a different BMI, risk profile, goals or prior treatment. Follow-up and loss to follow-up also differ.

When reading a number, match:

1. baseline BMI and conditions;
2. prior medications or procedures;
3. ESG device and suture pattern or surgical technique;
4. lifestyle and multidisciplinary program;
5. endpoint definition;
6. time point and retained participants;
7. revisions, conversions and concurrent medicines; and
8. adverse-event definitions.

Do not convert group averages into a personal forecast.

Risk profiles overlap but are not identical

Both procedures can involve anesthesia, bleeding, pain, nausea, dehydration, infection, clot risk, hospitalization, urgent endoscopy or surgery, and longer-term follow-up. ESG adds risks related to endoscopy, suturing, perforation, collections, suture failure and need for rescue or revision. Sleeve gastrectomy adds abdominal access, staple-line leak or bleeding, stricture, permanent resection and other surgical risks.

Reflux requires specific discussion. Sleeve anatomy and ESG may affect symptoms differently across patients and studies. Ask how baseline symptoms and objective findings are evaluated, what the center’s outcomes show, and which backup procedure is available if reflux or obstruction becomes a problem.

The emergency plan should identify an equipped hospital, accepting surgeon or endoscopist, imaging, after-hours contact, and transfer pathway. “Outpatient” does not mean complications can be managed by portal message.

Nutrition and maintenance outlast the procedure day

Both paths require a staged diet, hydration, protein and nutrition plan, medicine review, symptom monitoring, behavior support and long-term weight-management follow-up. Surgical sleeve can create specific micronutrient and gastrointestinal considerations; ESG still changes intake and can produce vomiting, intolerance or inadequate nutrition without support.

Ask who tracks weight trajectory, symptoms, nutrition, laboratory needs, eating behavior, activity, anti-obesity medicines, pregnancy planning and recurrence. Clarify whether follow-up is included for months or years and how care transfers if the endoscopist, surgeon or program changes.

Reversibility is often oversold

ESG does not remove stomach, but that does not mean it is effortlessly reversible or returns tissue to an untouched baseline. Sutures can be cut or revised in selected situations, anatomy and scarring may persist, and another endoscopic or surgical intervention has its own risk. Surgical sleeve permanently removes stomach; conversion is reconstruction, not reversal.

Ask for separate pathways for insufficient response, weight recurrence, persistent symptoms, suture disruption, reflux, obstruction, leak or another complication. Name who performs endoscopic revision, surgical conversion or emergency rescue.

A new code does not guarantee payment

CPT 43889 gives ESG a Category I code in 2026, improving procedural identification.⁴ Coverage still depends on the payer, benefit, policy, network, facility, eligibility, prior authorization, documentation and contract. A clinic’s ability to submit a code is not a promise of payment.

Compare total estimates for evaluation, endoscopy, surgery, anesthesia, facility, pathology if applicable, medicines, nutrition, imaging, follow-up, complications, revisions, conversions and travel. Obtain a Good Faith Estimate when self-paying and ask which foreseeable services come from separate entities.

1. Compare the anatomy Document transoral suturing versus gastric resection, devices, suture/staple plan and what permanently changes.
2. Match eligibility Use the exact label, guideline, center criteria, conditions, reflux/anatomy, prior care and follow-up capacity.
3. Normalize outcomes Keep denominator, baseline, intervention, medicines, program, endpoint, time point and retained cohort together.
4. Verify rescue Name hospital, endoscopist, surgeon, transfer, imaging and pathways for leak, bleeding, perforation, obstruction or failure.
5. Audit lifetime care and cost Include nutrition, monitoring, medicines, coverage, revisions, conversions, complications and record transfer.

Choose between complete care pathways

Ask: “What exact anatomy will change, why do I fit this procedure’s studied and labeled pathway, what long-term program and rescue system support it, and what happens if response or tolerance is inadequate?” A scope, a small incision, or a new billing code cannot answer that alone.